Health: pharmaceuticals; labeling of generic name on pharmaceutical blister packaging; require under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17748g.

HB 4252 requires drug manufacturers to display the generic name of non-controlled prescription medications on every blister cell of a blister pack, or on the backing if the pack lacks perforated cells. This applies directly to pharmaceutical companies and pharmacies distributing blister-packaged drugs in Michigan. The law aims to improve patient clarity by ensuring the generic drug name is clearly visible at the point of use, reducing confusion between brand and generic products. It amends Michigan's Public Health Code (MCL 333.1101 et seq.) without altering drug safety, cost, or availability.